Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

• Conditions: Oral Mucositis

• Registration Number: NCT00549952
• Lead Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.

Brief Summary

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

Detailed Description

Not available

Study Timeline

• Status Verified: 2007-10
• Study Start: 2007-10
• Study First Submitted: 2007-10-25
• Study First Submitted QC: 2007-10-25
• Last Update Submitted: 2007-10-25
• Study First Posted: 2007-10-26
• Last Update Posted: 2007-10-26
• Study Completion: 2008-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

Exclusion Criteria

• Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
• Patients with performance status of ECOG score is more than 3

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
incidence and severity of oral mucositis

Trial Locations

Locations (1)

Seoul National University hospital; 🇰🇷 Seoul, Korea, Republic of